1. Home
  2. EPSN vs ADAP Comparison

EPSN vs ADAP Comparison

Compare EPSN & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPSN
  • ADAP
  • Stock Information
  • Founded
  • EPSN 2005
  • ADAP 2008
  • Country
  • EPSN Canada
  • ADAP United Kingdom
  • Employees
  • EPSN N/A
  • ADAP N/A
  • Industry
  • EPSN Oil & Gas Production
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPSN Energy
  • ADAP Health Care
  • Exchange
  • EPSN Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • EPSN 139.0M
  • ADAP 158.6M
  • IPO Year
  • EPSN N/A
  • ADAP 2015
  • Fundamental
  • Price
  • EPSN $6.61
  • ADAP $0.58
  • Analyst Decision
  • EPSN Strong Buy
  • ADAP Strong Buy
  • Analyst Count
  • EPSN 1
  • ADAP 4
  • Target Price
  • EPSN $7.00
  • ADAP $2.79
  • AVG Volume (30 Days)
  • EPSN 32.0K
  • ADAP 2.3M
  • Earning Date
  • EPSN 11-06-2024
  • ADAP 03-05-2025
  • Dividend Yield
  • EPSN 3.81%
  • ADAP N/A
  • EPS Growth
  • EPSN N/A
  • ADAP N/A
  • EPS
  • EPSN 0.24
  • ADAP N/A
  • Revenue
  • EPSN $31,145,315.00
  • ADAP $175,041,000.00
  • Revenue This Year
  • EPSN N/A
  • ADAP $204.91
  • Revenue Next Year
  • EPSN $15.65
  • ADAP N/A
  • P/E Ratio
  • EPSN $27.52
  • ADAP N/A
  • Revenue Growth
  • EPSN N/A
  • ADAP 146.27
  • 52 Week Low
  • EPSN $4.70
  • ADAP $0.53
  • 52 Week High
  • EPSN $6.75
  • ADAP $2.05
  • Technical
  • Relative Strength Index (RSI)
  • EPSN 64.93
  • ADAP 41.87
  • Support Level
  • EPSN $6.11
  • ADAP $0.55
  • Resistance Level
  • EPSN $6.69
  • ADAP $0.65
  • Average True Range (ATR)
  • EPSN 0.26
  • ADAP 0.05
  • MACD
  • EPSN 0.02
  • ADAP 0.00
  • Stochastic Oscillator
  • EPSN 86.41
  • ADAP 31.31

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Share on Social Networks: